$Recursion Pharmaceuticals(RXRX.US) The medicine must not stop. Add another 10,000 shares
Arcus Biosciences
RCUS----
Arcus Biosciences (RCUS)
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company’s developmen...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
Arcus Biosciences Analyst Rating
View moreForecast & Rating
Oct 25, 2026Price forecast
$41.00122.95%
Forecast & RatingStrong buy
15analysts
- Strong buy80.00%
- Buy6.67%
- Hold13.33%
- Sell0.00%
- Strong sell0.00%
News
- Market Movers ·
Arcus Biosciences hits 52-week low
- StockTitan ·
Arcus Biosciences Announces New Employment Inducement Grants | RCUS Stock News
- Market Movers ·
Arcus Biosciences hit a new 52-week low in pre-market trading, currently at $16.79, down about 9%
- Simplywall ·
Arcus Biosciences (RCUS) Stock Dropped, What Is Behind The Fresh Attention?
- TradingView ·
Arcus Biosciences Closes $269.7 Million Stock Offering
- benzinga_article ·
12 Health Care Stocks Moving In Wednesday's After-Market Session